Home/Filings/4/0001415889-25-020200
4//SEC Filing

Peters Malte 4

Accession 0001415889-25-020200

CIK 0001760542other

Filed

Jul 22, 8:00 PM ET

Accepted

Jul 23, 6:09 PM ET

Size

5.1 KB

Accession

0001415889-25-020200

Insider Transaction Report

Form 4
Period: 2025-07-22
Peters Malte
DirectorChief Executive Officer
Transactions
  • Sale

    Common Stock

    2025-07-22$0.92/sh29,176$26,84279,519 total
Footnotes (1)
  • [F1]This sale was affected pursuant to a "sell to cover" arrangement adopted by the Issuer to satisfy the tax withholding obligations triggered by the vesting of restricted stock units granted on July 22, 2024 and does not represent a discretionary trade by the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

Issuer

HOOKIPA Pharma Inc.

CIK 0001760542

Entity typeother

Related Parties

1
  • filerCIK 0001876563

Filing Metadata

Form type
4
Filed
Jul 22, 8:00 PM ET
Accepted
Jul 23, 6:09 PM ET
Size
5.1 KB